Ovizio raises €8m ($9.1m) with US and Belgian investors

We are pleased to announce our funding round of €8M ($ 9.1 M). The proceeds of the capital round will be used to accelerate our activities in the bioprocessing and cell counting industries, to develop our technology and to expand our product offering. We will use the funds to strengthen our core R&D team with five new hires this year and a further ten in 2016

This funding round was co-led by New Science Ventures, a US-based venture capital firm, and a private investor and also includes Qbic, Nausicaa Ventures, Theodorus III, Mr. Pierre Drion and a few other private investors.

See complete press release